PFBT
MDGL icon

Parkside Financial Bank & Trust’s Madrigal Pharmaceuticals MDGL Stock Holding History

Parkside Financial Bank & Trust’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.91K Buy
11
+1
+10% +$512 ﹤0.01% 1846
2026
Q1 		$5.24K Hold
10
– – ﹤0.01% 1807
2025
Q4 		$5.82K Hold
10
– – ﹤0.01% 1755
2025
Q3 		$4.59K Buy
10
+2
+25% +$746 ﹤0.01% 1763
2025
Q2 		$2.42K Sell
8
-2
-20% -$596 ﹤0.01% 1933
2025
Q1 		$3.31K Buy
+10
New +$3.29K ﹤0.01% 1754

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parkside Financial Bank & Trust's MDGL Position: Q2 2026 in Review

Parkside Financial Bank & Trust increased its Madrigal Pharmaceuticals (MDGL) stake by 10% in Q2 2026, buying an estimated $512 and bringing the position to 11 shares worth $5.91K. The position accounts for ﹤0.01% of the portfolio, ranked #1846.

Parkside Financial Bank & Trust first reported a position in MDGL in Q1 2025 and has held it in 6 quarters since. 414 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Parkside Financial Bank & Trust held 11 shares of Madrigal Pharmaceuticals worth $5.91K as of Q2 2026.
  • Parkside Financial Bank & Trust bought 1 Madrigal Pharmaceuticals share in Q2 2026, an estimated $512.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #1846 holding.
  • Parkside Financial Bank & Trust first reported a position in Madrigal Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 414 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.